Thomas Andrew Crockett is CEO of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 211,203 shares of KALV, which is worth approximately $2.59 Million. The most recent transaction as insider was on Jun 09, 2021, when has been sold 8,933 shares (Common Stock) at a price of $30.05 per share, resulting in proceeds of $268,437. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 211K
0% 3M change
64.94% 12M change
Total Value Held $2.59 Million

Thomas Andrew Crockett Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 09 2021
SELL
Open market or private sale
$268,437 $30.05 p/Share
8,933 Reduced 5.78%
145,737 Common Stock
Apr 29 2021
SELL
Bona fide gift
-
4,750 Reduced 2.98%
154,670 Common Stock
Apr 01 2021
SELL
Open market or private sale
$272,700 $27.27 p/Share
10,000 Reduced 5.9%
159,420 Common Stock
Feb 23 2021
SELL
Open market or private sale
$334,900 $33.49 p/Share
10,000 Reduced 5.57%
169,420 Common Stock
Jan 04 2021
SELL
Open market or private sale
$184,900 $18.49 p/Share
10,000 Reduced 5.12%
185,420 Common Stock
Oct 29 2020
SELL
Bona fide gift
-
6,000 Reduced 3.24%
179,420 Common Stock
Oct 21 2020
SELL
Open market or private sale
$413,250 $18.33 p/Share
22,545 Reduced 10.34%
195,420 Common Stock
Oct 20 2020
SELL
Open market or private sale
$282,134 $17.64 p/Share
15,994 Reduced 6.84%
217,965 Common Stock
Oct 16 2020
SELL
Open market or private sale
$21,450 $17.01 p/Share
1,261 Reduced 0.53%
236,959 Common Stock
Apr 29 2020
SELL
Bona fide gift
-
3,000 Reduced 1.27%
233,959 Common Stock
TAC

Thomas Andrew Crockett

CEO
Cambridge, MA

Track Institutional and Insider Activities on KALV

Follow KalVista Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

News

Receive news related to KalVista Pharmaceuticals, Inc.

Track Activities on KALV